The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Prevalence of Immunosuppression Among US Adults, 2013
Open accessAbstract
immunosuppression increased with age, in parallel with the epidemiology of prevalent conditions that require immunosuppressive treatments, but it is unclear why it peaked at ages 50 to 59 years.The study has limitations.Self-reports of immunosuppression are prone to misclassification, but the modest range of results in the sensitivity analyses provides reassurance regarding the potential influence of erroneous responses.With a limited number of survey questions, causes or subsets of immunosuppression could not be reliably determined.It is unknown whether data from 2013 reflect the current prevalence of immunosuppression.In addition, the study excluded children and institutionalized adults.This study addresses an underappreciated phenomenon and serves as a call for additional data from other sources to complement and fill the gaps in the study.Tracking immunosuppression over time is particularly important given the hundreds of clinical trials now under way to assess the use of immunosuppressive treatments for prevention or mitigation of common chronic diseases in highly prevalent risk groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,417
Emerging Infections: Microbial Threats to Health in the United States
Lederberg, J., Shope, R. E., & Oaks, S. C. (1992) · Defense Technical Information Center (DTIC) · Cited by 772
Memoli, M. J., Athota, R., Reed, S., Czajkowski, L., Bristol, T., Proudfoot, K., Hagey, R., Voell, J., Fiorentino, C., Ademposi, A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit725 · Cited by 274
Novosad, S., & Winthrop, K. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu104 · Cited by 50
Cited by
Azoulay, E., Lemiale, V., Mokart, D., Nseir, S., Argaud, L., Pène, F., Kontar, L., Bruneel, F., Klouche, K., Barbier, F., et al. (2018) · JAMA · doi:10.1001/jama.2018.14282 · Cited by 333
Deshmukh, A. A., Suk, R., Shiels, M. S., Sonawane, K., Nyitray, A. G., Liu, Y., Gaisa, M. M., Palefsky, J. M., & Sigel, K. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz219 · Cited by 327
for the Efraim investigators and the Nine-I study group, Azoulay, E., Pickkers, P., Soares, M., Perner, A., Rello, J., Bauer, P. R., van de Louw, A., Hemelaar, P., Lemiale, V., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4947-1 · Cited by 302
Sun, J., Zheng, Q., Madhira, V., Olex, A. L., Anzalone, A. J., Vinson, A., Singh, J. A., French, E., Abraham, A. G., Mathew, J., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.7024 · Cited by 265
Hodges, M. R., Ople, E., Wedel, P., Shaw, K. J., Jakate, A., Kramer, W. G., Marle, S. V., van Hoogdalem, E.-J., & Tawadrous, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-22 · Cited by 52
Metadata
- Authors
- Harpaz, R., Dahl, R. M., & Dooling, K. L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-12-20
- Volume
- 316
- Issue
- 23
- Pages
- 2547
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2541557701
- Cited by
- 266
- References
- 5
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Immunosuppression Among US Adults, 2013. https://app.cochat.ai/papers/10.1001/jama.2016.16477
- The paper
- Harpaz, R., Dahl, R. M., & Dooling, K. L. (2016). Prevalence of Immunosuppression Among US Adults, 2013. JAMA. https://doi.org/10.1001/jama.2016.16477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.